Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02137096 · ClinicalTrials.gov registry record · Phase 3
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
A Phase 3 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT02137096: Clinical Trial Phase 3 study, sponsored by University of Florida.
NCT02137096 is a Phase 3 study that was terminated before completion, run by University of Florida. The registered enrollment target is 1 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02137096, a Phase 3 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the response rates for patients undergoing high dose conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in children, adolescents, and young adults.
Primary Outcome
To evaluate the response rates for patients undergoing high dose conditioning using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent NPC in children, adolescents, and young adults.
Interventions
- DRUG Carboplatin
- DRUG Ifosfamide
- DRUG Etoposide phosphate
- PROCEDURE Autologous Stem Cell Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-05-09 |
| Phase | Phase 3 |
Why NCT02137096 stopped before completion
NCT02137096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Carboplatin is the first listed.
NCT02137096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02137096 about?
NCT02137096 is a clinical study titled "Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma". This is a pilot study to evaluate the response rates for patients undergoing high dose conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in children, adolescents, and young...
What is the current status of trial NCT02137096?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2014-06. Estimated completion is 2017-05-09.
What interventions are being tested in trial NCT02137096?
The interventions under investigation include: Carboplatin (DRUG), Ifosfamide (DRUG), Etoposide phosphate (DRUG), Autologous Stem Cell Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT02137096?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02137096's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia